Does Argus HQ track new FDA actions for Accriva Diagnostics, Inc. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Accriva Diagnostics, Inc. is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Accriva Diagnostics, Inc.?

1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Accriva Diagnostics, Inc.?

June 24, 2026. Argus HQ ingests new FDA enforcement records daily.

Has Accriva Diagnostics, Inc. had product recalls?

Yes, 1 recall on file. See the full history below for each one.

Accriva Diagnostics, Inc. — FDA Compliance Timeline

Here's the summary: Argus HQ has recorded 1 FDA events for Accriva Diagnostics, Inc.: 0 warning letters, 1 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-06-24 to 2026-06-24. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	1
Warning letters	0
Recalls	1
Approval records	0
Form 483 inspection citations	0
Most recent action	June 24, 2026

Enforcement history

On 2026-06-24, Argus HQ recorded an FDA recall for Accriva Diagnostics, Inc., rated "high" severity in Argus HQ's classification: Accriva Diagnostics, Inc. — Class II recall: directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: D…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Accriva Diagnostics, Inc. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

Does Argus HQ track new FDA actions for Accriva Diagnostics, Inc. automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Accriva Diagnostics, Inc. is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Accriva Diagnostics, Inc.?: 1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Accriva Diagnostics, Inc.?: June 24, 2026. Argus HQ ingests new FDA enforcement records daily.
Has Accriva Diagnostics, Inc. had product recalls?: Yes, 1 recall on file. See the full history below for each one.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Accriva Diagnostics, Inc. — Class II recall: directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: D… →

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Jun 24, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Accriva Diagnostics, Inc. — FDA Compliance Timeline. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/accriva-diagnostics-inc

MLA

"Accriva Diagnostics, Inc. — FDA Compliance Timeline." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/accriva-diagnostics-inc.

Chicago

Argus HQ Research. "Accriva Diagnostics, Inc. — FDA Compliance Timeline." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/accriva-diagnostics-inc.

BibTeX

@misc{argushq_argushq_ai_company_accriva_diagnostics_inc_2026,
  title = {Accriva Diagnostics, Inc. — FDA Compliance Timeline},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/accriva-diagnostics-inc},
  note = {Accessed: August 29, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗